98 related articles for article (PubMed ID: 1842173)
1. Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.
Wong JH; Xu SH; Skinner KA; Foshag LJ; Morton DL
Arch Surg; 1991 Dec; 126(12):1450-4. PubMed ID: 1842173
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated antigen immune complexes. A potential marker of recurrent melanoma.
Wong JH; Xu SH; Gupta RK; Morton DL
Arch Surg; 1990 Feb; 125(2):187-91. PubMed ID: 2302059
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated antigen TA-90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma.
Kelley MC; Jones RC; Gupta RK; Yee R; Stern S; Wanek L; Morton DL
Cancer; 1998 Oct; 83(7):1355-61. PubMed ID: 9762936
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
Morgan AC; McIntyre RF
Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
[TBL] [Abstract][Full Text] [Related]
5. Detection and isolation of antigen-specific immune complexes from sera of melanoma patients.
Wong JH; Xu SH; Saxton RE; Gupta RK; Morton DL
Int J Cancer; 1990 Mar; 45(3):445-9. PubMed ID: 1689702
[TBL] [Abstract][Full Text] [Related]
6. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
Wong JH; Aguero B; Gupta RK; Morton DL
Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
[TBL] [Abstract][Full Text] [Related]
7. Circulating melanoma-associated antigens in ocular melanoma.
Whitmore WG; Witkin SS; Ellsworth RM
Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
[TBL] [Abstract][Full Text] [Related]
8. Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay.
Euhus DM; Gupta RK; Morton DL
J Clin Lab Anal; 1989; 3(3):184-90. PubMed ID: 2754533
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-based ELISA to detect glycoprotein tumor-associated-antigen-specific immune complexes in cancer patients.
Gupta RK; Morton DL
J Clin Lab Anal; 1992; 6(5):329-36. PubMed ID: 1403355
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma.
Curry BJ; Myers K; Hersey P
J Clin Oncol; 1998 May; 16(5):1760-9. PubMed ID: 9586889
[TBL] [Abstract][Full Text] [Related]
11. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
Litvak DA; Gupta RK; Yee R; Wanek LA; Ye W; Morton DL
J Am Coll Surg; 2004 Jan; 198(1):27-35. PubMed ID: 14698308
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.
Kelley MC; Gupta RK; Hsueh EC; Yee R; Stern S; Morton DL
J Clin Oncol; 2001 Feb; 19(4):1176-82. PubMed ID: 11181684
[TBL] [Abstract][Full Text] [Related]
13. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
Wong JH; Gupta RK; Morton DL
Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
[TBL] [Abstract][Full Text] [Related]
14. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a 90kD subunit containing glycoprotein tumor-associated antigen specific immune complexes in lung cancer patients.
Gupta RK; Morton DL
Dis Markers; 1994 Oct; 12(1):51-61. PubMed ID: 7842631
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in malignant melanoma.
Gupta RK
Dis Markers; 1988 Jun; 6(2):81-95. PubMed ID: 3042263
[No Abstract] [Full Text] [Related]
17. Immune complexes in human melanoma: a consequence of deranged immune regulation.
Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and nature of circulating immune complexes in melanoma patients.
Gupta RK; Morton DL
Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
[No Abstract] [Full Text] [Related]
19. Detection of epithelial ovarian-cancer-associated antigens involved in immune complexes by monoclonal antibodies.
Kawata M; Sekiya S
Tumour Biol; 1998; 19(1):1-11. PubMed ID: 9422077
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients.
Savar A; Ross MI; Prieto VG; Ivan D; Kim S; Esmaeli B
Ophthalmology; 2009 Nov; 116(11):2217-23. PubMed ID: 19766318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
